Watchlist Price Alert

Landos Biopharma Inc. (LABP)

NASDAQ: LABP · Real-Time Price · USD

22.93

0.13 (0.57%)

At close: May 23, 2024, 8:00 PM

Landos Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-21.93M	-39.28M	-38.42M	-30.14M	-13.47M	-6.04M
Depreciation & Amortization	44K	577K	196K	137K	103K	80K
Stock-Based Compensation	971K	1.97M	4.12M	833K	n/a	n/a
Other Working Capital	2.57M	-601K	1.63M	-635K	2.86M	-2.3M
Other Non-Cash Items	-2.13M	1.03M	1.16M	48K	213K	369K
Deferred Income Tax	2.13M	n/a	n/a	293K	n/a	n/a
Change in Working Capital	443K	-10.07M	5.89M	5.87M	3.28M	-1.3M
Operating Cash Flow	-20.48M	-45.77M	-27.06M	-22.96M	-9.87M	-6.9M
Capital Expenditures	n/a	-7K	-440K	-181K	-158K	-43K
Cash Acquisitions	n/a	236K	-235K	88K	n/a	n/a
Purchase of Investments	n/a	-3.67M	-174.85M	-21.72M	-40.32M	n/a
Sales Maturities Of Investments	7.78M	77.5M	116.59M	36.03M	152K	n/a
Other Investing Acitivies	-57K	n/a	235K	-88K	n/a	n/a
Investing Cash Flow	7.78M	74.06M	-58.71M	14.13M	-40.33M	-43K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-3M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	13.57M	n/a	91.61M	1.52M	59.65M	5M
Financial Cash Flow	13.57M	n/a	91.61M	1.52M	59.65M	5M
Net Cash Flow	909K	28.34M	5.89M	-7.39M	9.45M	-1.94M
Free Cash Flow	-20.48M	-45.78M	-27.5M	-23.14M	-10.03M	-6.94M